Sumitomo Dainippon Pharma (Japan) — Japan
Neuroscience · Life Sciences
9h-index733citations12works1.02yr avg
Accepting Students?
No reports yet. Know if this professor is taking students?
Research Topics
Tryptophan and brain disorders(9), Epigenetics and DNA Methylation(4), Schizophrenia research and treatment(3), Histone Deacetylase Inhibitors Research(2), Cancer-related gene regulation(2)
Publications12 total
npj Parkinson s Disease·2025· 1 citedOpen Access
Neuropsychopharmacology·2018· 5 citedOpen Access
Neuroscience·2018· 41 citedOpen Access
Neuropsychopharmacology·2018· 50 citedOpen Access
Nature Neuroscience·2017· 101 citedOpen Access
Molecular Pharmacology·2013· 39 citedOpen Access
Expert Review of Neurotherapeutics·2012· 22 citedOpen Access
Nature Neuroscience·2012· 284 cited
Journal of Neuroscience·2011· 119 citedOpen Access
Journal of Neuroscience·2006· 62 citedOpen Access
Biological and Pharmaceutical Bulletin·2002· 9 citedOpen Access
Frequent Co-authors
Javier González‐Maeso(9), Terrell Holloway(6), Aintzane García‐Bea(4), José L. Moreno(4), Mario de la Fuente Revenga(4), Maryum K. Ijaz(4), Alexey Kozlenkov(3), Scott J. Russo(3), Daisuke Ibi(3), Travis Cuddy(3), Rudy Toneatti(3), Giuseppe Mocci(2), James B. Hanks(2), Luís F. Callado(2), Rachael L. Neve(2), Li Shen(2), Eric J. Nestler(2), J. Javier Meana(2), Justin M. Saunders(2), Jeremy Seto(2)